Press release
Intravenous (IV) Equipment Market to Reach USD 17.6 Billion by 2034
The Global Intravenous (IV) Equipment Market is witnessing robust growth as healthcare systems modernize delivery methods for fluids, nutrients, and drugs. According to Exactitude Consultancy, the market, valued at USD 10.8 billion in 2024, is projected to reach USD 17.6 billion by 2034, growing at a CAGR of 5.0 % during 2025-2034.This expansion is supported by increasing chronic illness prevalence, demand for precise drug administration, and the rise of home-based infusion care.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/48311
Key Takeaways
• Market Size: USD 10.8 billion (2024) → USD 17.6 billion (2034)
• CAGR: 5.0 % (2025-2034)
• Top Products: IV Catheters, Infusion Pumps, and Administration Sets
• Leading End User: Hospitals dominate; home healthcare shows fastest growth
• Regional Leader: North America leads global adoption; Asia-Pacific grows fastest
Market Story
Intravenous (IV) therapy is essential for fluid management, medication delivery, and nutritional support in clinical and home settings. The market is evolving rapidly as technological innovations enhance safety, accuracy, and patient comfort.
Manufacturers are focusing on smart infusion pumps with digital controls, closed-system transfer devices (CSTDs) to prevent contamination, and needle-free connectors to minimize infection risks. The growing shift toward home healthcare for chronic conditions such as diabetes, cancer, and renal failure is also fueling demand for portable IV systems and remote monitoring solutions.
Additionally, global aging trends and the surge in hospital admissions post-pandemic have amplified the need for reliable IV therapy infrastructure in both developed and emerging markets.
Segmentation Overview
By Product Type
• IV Catheters
• Infusion Pumps (Volumetric, Syringe, Ambulatory)
• Administration Sets & Tubing
• Needleless Connectors
• Valves
• Fluid Bags and Solutions
By End User
• Hospitals
• Ambulatory Surgical Centers
• Homecare Settings
• Clinics and Specialty Centers
By Application
• Oncology
• Parenteral Nutrition
• Pain Management
• Antibiotic Administration
• Hydration Therapy
• Others
By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa
Explore Full Report here: https://exactitudeconsultancy.com/reports/48311/intravenous-iv-market
Recent Developments
• Becton, Dickinson and Company (BD) launched a new generation of safety-engineered IV catheters designed to reduce blood exposure and improve clinician protection.
• Baxter International Inc. introduced smart infusion systems with cloud connectivity for real-time dosage monitoring and data analytics.
• ICU Medical, Inc. expanded its Plum 360 Infusion Platform globally, integrating advanced pump interoperability with EHR systems.
• Fresenius Kabi AG invested in manufacturing expansion for IV fluids and parenteral nutrition solutions in Asia and Europe.
• Smiths Medical launched its next-generation CSTD-compatible infusion sets, enhancing oncology and critical care safety.
Expert Quote
"The intravenous equipment market is transitioning toward intelligent, patient-centric systems.
Innovations in safety design, automation, and home infusion care are setting new standards in efficiency and reliability,"
said Irfan Tamboli, Business Development Executive at Exactitude Consultancy.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=48311
Market Drivers
• Growing incidence of chronic diseases and hospital admissions
• Rapid adoption of smart, connected infusion systems
• Expansion of homecare and outpatient infusion services
• Rising emphasis on infection prevention and closed-system delivery
• Advancements in parenteral nutrition and oncology infusion therapies
Forecast and Outlook
By 2034, the IV equipment market will evolve toward fully digitized infusion ecosystems integrating AI-assisted flow control, wireless monitoring, and real-time dosing analytics. Hospitals will continue to account for the largest revenue share, but home infusion therapy is projected to grow at over 6.5 % CAGR, supported by telemedicine platforms and insurance coverage expansion.
Sustainability trends are also shaping the market, with manufacturers adopting biodegradable materials and recyclable polymer components to align with global green healthcare goals.
Regional Insights
• North America: Largest share due to strong hospital infrastructure and adoption of smart infusion technologies.
• Europe: Growth supported by increasing chronic disease management programs and hospital digitalization.
• Asia-Pacific: Fastest-growing region; large patient base, rapid healthcare investment, and domestic IV fluid production.
• Latin America: Expanding access to IV therapies through private hospitals and health insurance programs.
• Middle East & Africa: Steady growth driven by modernization of tertiary care facilities.
Conclusion
The Global Intravenous (IV) Equipment Market stands at the intersection of safety, technology, and accessibility.
As demand for advanced infusion therapy expands across hospitals and homecare environments, companies that prioritize automation, infection control, and connectivity will capture the next wave of growth in global healthcare delivery.
This report is also available in the following languages : Japanese (静脈内(IV)), Korean (정맥 주사(IV)), Chinese (静脉注射(IV)), French (Intraveineux (IV)), German (Intravenös (IV)), and Italian (Endovenoso (EV)), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/48311/intravenous-iv-market#request-a-sample
Related Reports
Graves Ophthalmopathy Market
https://exactitudeconsultancy.com/reports/72230/graves-ophthalmopathy-market
Intravenous Immunoglobulin Market
https://exactitudeconsultancy.com/reports/72414/intravenous-immunoglobulin-market
Superficial Vein Devices Market
https://exactitudeconsultancy.com/reports/72441/superficial-vein-devices-market
Bevacizumab Biosimilars Market
https://exactitudeconsultancy.com/reports/72673/bevacizumab-biosimilars-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Intravenous (IV) Equipment Market to Reach USD 17.6 Billion by 2034 here
News-ID: 4261053 • Views: …
More Releases from Exactitude Consultancy
Disposable Medical Mask Meltblown Nonwoven Fabric Market to Reach USD 2.43 Billi …
Post-Pandemic Healthcare Modernization, Air Quality Concerns, and Technological Advancements in Polypropylene Meltblown Fabrics Sustain Long-Term Market Growth
The Global Disposable Medical Mask Meltblown Nonwoven Fabric Market is witnessing steady growth as healthcare systems, industrial facilities, and consumers maintain high standards for respiratory protection and hygiene. According to Exactitude Consultancy, the market, valued at USD 1.67 billion in 2024, is projected to reach USD 2.43 billion by 2034, expanding at a CAGR…
U.S. Post-Acute Care (PAC) Market to Reach USD 635.8 Billion by 2034
The U.S. Post-Acute Care (PAC) Market is experiencing robust transformation as the nation's healthcare system shifts toward coordinated recovery, aging-in-place programs, and value-based reimbursement models. According to Exactitude Consultancy, the market, valued at USD 425.9 billion in 2024, is projected to reach USD 635.8 billion by 2034, growing at a CAGR of 4.1 % during 2025-2034.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/48317
This growth is driven by an…
Nicotinamide Mononucleotide (NMN) Market to Reach USD 580.4 Million by 2034
NMN Gains Mainstream Momentum as Consumers Seek Cellular Health, Metabolic Support, and Age-Reversal Benefits
The Global Nicotinamide Mononucleotide (NMN) Market is witnessing a remarkable surge as scientific validation and consumer awareness converge around the molecule's potential to slow aging, enhance cellular repair, and support energy metabolism. According to Exactitude Consultancy, the market, valued at USD 280.7 million in 2024, is expected to reach USD 580.4 million by 2034, growing at an…
Tuberculosis (TB) Diagnostics Market to Reach USD 4.93 Billion by 2034
The Global Tuberculosis Diagnostics Market is expanding steadily as healthcare systems strengthen early detection and disease-control efforts. According to Exactitude Consultancy, the market, valued at USD 3.12 billion in 2024, is projected to reach USD 4.93 billion by 2034, registering a CAGR of 4.6 % from 2025 to 2034.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/48300
The surge is fueled by the increasing prevalence of drug-resistant tuberculosis, the integration…
More Releases for Intravenous
Future Outlook of the Soliris Intravenous Market: Soliris Intravenous Trends and …
The global Soliris Intravenous Market was valued at approximately USD 3.5 billion in 2024 and is projected to reach around USD 6.8 billion by 2033, growing at a compound annual growth rate (CAGR) of about 7.5% from 2025 to 2033.
Request a sample copy of this report at: https://www.omrglobal.com/request-sample/soliris-intravenous-market
Soliris Intravenous Market Overview:
The Soliris Intravenous Market is experiencing steady growth driven by the increasing prevalence of rare and chronic diseases such as…
Global Large Volume Intravenous Solution Market Size by Application, Type, and G …
USA, New Jersey- According to Market Research Intellect, the global Large Volume Intravenous Solution market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The large volume intravenous (IV) solution market is experiencing robust growth, fueled by the increasing prevalence of chronic diseases, rising surgical procedures, and…
Intravenous Iron Drugs Market
The "Intravenous Iron Drugs Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023.
Growing Demand and Growth Potential in the Global Intravenous Iron Drugs Market, 2024-2031
Verified Market Research's most recent report, "Intravenous Iron Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides…
Intravenous (IV) Solutions Market
The Global Intravenous (IV) Solution Market is expected to reach USD 11,511.2 million by 2022 and is expected to grow at a CAGR of 7.69% during the forecast period 2016-2022. The factors which drive the growth of the market are the rising prevalence of chronic diseases, rising acceptance of vitamin C intravenous treatment therapy to treat colorectal cancer.
Key Finding
The global Intravenous (IV) Solution market and is expected to reach USD…
Intravenous Solutions Market Opportunity Analysis, 2026
Intravenous solutions are the chemically prepared fluids, which are administered in the body through venous circulation to maintain or replace the lost body fluid level. There are various types of IV solutions that have different effects on a human body. Majority of intravenous solutions constitute of solvent and solute out of which solvents are sterile water and solutes are electrolytes such as sodium, potassium, and chloride. Intravenous solutions market is…
Intravenous Product Packaging Market -
Global healthcare sector continues to develop at an impressive rate. As a result, packaging marketplace is undergoing huge changes with specialized focus on offering innovative packaging tools/products to pharmaceutical industry. One such core product that offers lucrative market opportunities for packaging companies is intravenous products.
Download PDF Brochure For Future Advancements@ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14075
Intravenous product such as catheters and IV fluid bags are mainly used to prevent and treat various chronic illness…
